Articles Tagged With:
-
BPCI Initiative Cuts Readmissions, Costs for Patients Having Cardiac Valve Surgery
After Vanderbilt University Medical Center began a bundled payment project for patients who had cardiac valve replacement or valve repair surgery, readmissions for those patients dropped by 20% and the cost of care decreased at the same time.
-
Provider Partnerships Must go Beyond Collaboration, Include Data Sharing
The significant role that post-acute care plays in bundled payments makes it crucial for hospitals to identify providers that perform the best and enter into agreements with them to establish a high-performing post-acute network
-
Bundled Payments Take a Lot of Work — So You Better Start Now
CMS has given providers only a short time frame in which to go live with their bundled payments programs — which makes it difficult for providers to prepare.
-
Get Ready for Bundled Payments: They’re Coming Your Way
If your hospital is not in one of the geographic areas where the CMS mandated that hospitals participate in the Comprehensive Care for Joint Replacement program, don’t think you’ve dodged the bundled payment bullet.
-
The Hidden Costs of an Epidemic
Naloxone prices explode while medical professionals scramble to treat the fast-growing opioid addiction population.
-
New Center Focuses on Improving Emergency Care for Children
The Emergency Medical Services for Children Innovation and Improvement Center will ensure every child has access to pediatric emergency care or urgent care.
-
Predicting Opioid Abuse and Dependence
It is critical to learn how to better identify patients at risk of opioid addiction, abuse, and dependence.
-
Updates on the USPSTF Colorectal Cancer Screening Recommendations
In accordance with previous recommendations, the United States Preventive Services Task Force still endorses colorectal cancer screening in adults 50-75 years of age.
-
SPRINT: Celebrating Benefits for Older Patients
Using available knowledge, age should not be considered a barrier to seeking good blood pressure control.
-
Many Treatment Choices for Type 2 Diabetes
Despite an impressive amount of data, no particular class of agents — as monotherapy or in combination — provided distinct advantages for risk reduction of cardiovascular events or mortality.